Skip to main content
  •   Home
  •   Download
  •   Manual
  •   Contact

Drug Combination Details

General Information of the Combination (ID: C22796)
Name Alpha solanine + 5-fluorouracil + Cisplatin
    Click to Show/Hide the Each NP or Drug Information of This Combination
Name Alpha solanine   NP Info     Drug Info 
Structure
Name    Drug Info 
Structure
Disease
Esophageal cancer [ICD-11: 2B70]
Investigative [1]
Combinatorial Therapeutic Effect(s) Validated Clinically or Experimentally
    α. Enhancing Drug Efficacy by This Combination
                 Achieving Therapeutic Synergy     Click to Show/Hide
                    Experiment 1 Reporting the Effect of This Combination [1]
                    Molecule(s)
                    Regulation
Down-regulation Expression BIRC5  Molecule Info 
Pathway MAP
                    In-vitro Model EC9706 CVCL_E307 Esophageal squamous cell carcinoma Homo sapiens
KYSE-30 CVCL_1351 Esophageal squamous cell carcinoma Homo sapiens
                    In-vivo Model EC9706 cells (5*106), which were labeled with firefly luciferase, were subcutaneously inoculated into the armpit of the right forelimb of 6-week-old female BALB/c nude mice.
                    Experimental
                    Result(s)
Alpha-solanine enhances the chemosensitivity of esophageal cancer cells by inducing microRNA 138 expression.
References
Reference 1 Alpha-solanine enhances the chemosensitivity of esophageal cancer cells by inducing microRNA?138 expression. Oncol Rep. 2018 Mar;39(3):1163-1172.
 Download Picture         KEGG Link      
Cite NPCDR
Visitor Map
Correspondence

X. N. Sun, Y. T. Zhang, Y. Zhou, X. C. Lian, L. L. Yan, T. Pan, T. Jin, H. Xie, Z. M. Liang, W. Q. Qiu, J. X. Wang, Z. R. Li, F. Zhu*, X. B. Sui*. NPCDR: natural product-based drug combination and its disease-specific molecular regulation. Nucleic Acids Research. 50(D1): 1324-1333 (2020). PMID: 34664659

Prof. Feng ZHU  (zhufeng@zju.edu.cn)

College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China


Prof. Xinbing SUI  (hzzju@hznu.edu.cn)

School of Pharmacy and Department of Medical Oncology, the Affiliated Hospital of Hangzhou Normal University, Hangzhou Normal University, Hangzhou, China